Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study.

IF 2.6 4区医学 Q1 MEDICINE, GENERAL & INTERNAL Medicina Clinica Pub Date : 2024-11-11 DOI:10.1016/j.medcli.2024.09.008

José Ángel Novalbos-Partida, José Antonio Rueda-Camino, María Angelina-García, M Dolores Joya-Seijo, Davinia Trujillo-Luque, Raquel Barba-Martín

{"title":"Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study.","authors":"José Ángel Novalbos-Partida, José Antonio Rueda-Camino, María Angelina-García, M Dolores Joya-Seijo, Davinia Trujillo-Luque, Raquel Barba-Martín","doi":"10.1016/j.medcli.2024.09.008","DOIUrl":null,"url":null,"abstract":"Objectives: Prognostic differences between central venous catheters (CVC) carriers and non-carriers, who have upper extremity deep vein thrombosis (UEDVT), have been described; however, evidence in hospitalized patients is limited.Materials and methods: This retrospective cohort study included hospitalized patients from March 2012 to March 2023 with UEDVT, classified into CVC-associated and non-CVC-associated UEDVT groups. Rates of thrombotic recurrence, hemorrhage, post-thrombotic syndrome, and death from pulmonary embolism were analyzed using Kaplan-Meier curves and Cox proportional hazards models.Results: A total of 135 patients were included (76 with CVC and 59 without CVC), with a mean age of 67±15 years and 44% female. No significant differences were observed in the incidence of the combined endpoint between CVC non-carriers and carriers (5.45 vs 6.74 per 1000 patient-months respectively; HR: 1.26; 95% CI: 0.51-3.06). After multivariable adjustment, no significant differences in risk were detected (HR: 1.09; 95% CI: 0.44-2.72).Conclusions: There are no significant prognostic differences between patients with and without CVC hospitalized for UEDVT.","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Clinica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.medcli.2024.09.008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Prognostic differences between central venous catheters (CVC) carriers and non-carriers, who have upper extremity deep vein thrombosis (UEDVT), have been described; however, evidence in hospitalized patients is limited.

Materials and methods: This retrospective cohort study included hospitalized patients from March 2012 to March 2023 with UEDVT, classified into CVC-associated and non-CVC-associated UEDVT groups. Rates of thrombotic recurrence, hemorrhage, post-thrombotic syndrome, and death from pulmonary embolism were analyzed using Kaplan-Meier curves and Cox proportional hazards models.

Results: A total of 135 patients were included (76 with CVC and 59 without CVC), with a mean age of 67±15 years and 44% female. No significant differences were observed in the incidence of the combined endpoint between CVC non-carriers and carriers (5.45 vs 6.74 per 1000 patient-months respectively; HR: 1.26; 95% CI: 0.51-3.06). After multivariable adjustment, no significant differences in risk were detected (HR: 1.09; 95% CI: 0.44-2.72).

Conclusions: There are no significant prognostic differences between patients with and without CVC hospitalized for UEDVT.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

住院中心静脉导管携带者和非携带者的上肢深静脉血栓形成：一项回顾性队列研究。

目的：中心静脉导管（CVC）携带者和非携带者在上肢深静脉血栓形成（UEDVT）的预后方面存在差异，但住院患者的证据有限：这项回顾性队列研究纳入了 2012 年 3 月至 2023 年 3 月期间患有 UEDVT 的住院患者，分为 CVC 相关 UEDVT 组和非 CVC 相关 UEDVT 组。研究采用 Kaplan-Meier 曲线和 Cox 比例危险模型分析了血栓复发率、出血率、血栓后综合征和肺栓塞致死率：共纳入135例患者（76例使用CVC，59例未使用CVC），平均年龄（67±15）岁，女性占44%。非 CVC 携带者和携带者的合并终点发病率无明显差异（分别为每 1000 患者月 5.45 例和 6.74 例；HR：1.26；95% CI：0.51-3.06）。经多变量调整后，未发现明显的风险差异（HR：1.09；95% CI：0.44-2.72）：结论：因 UEDVT 住院的患者中，有 CVC 和没有 CVC 的患者在预后方面没有明显差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Medicina Clinica 医学-医学：内科

CiteScore

3.10

自引率

5.10%

发文量

295

审稿时长

22 days

期刊介绍： Medicina Clínica, fundada en 1943, es una publicación quincenal dedicada a la promoción de la investigación y de la práctica clínica entre los especialistas de la medicina interna, así como otras especialidades. Son características fundamentales de esta publicación el rigor científico y metodológico de sus artículos, la actualidad de los temas y, sobre todo, su sentido práctico, buscando siempre que la información sea de la mayor utilidad en la práctica clínica.